Literature DB >> 17404859

Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?

Ali Rezaie1, Robyn D Parker, Mohammad Abdollahi.   

Abstract

Crohn's disease (CD) and ulcerative colitis (UC), known as inflammatory bowel disease (IBD), are fairly common chronic inflammatory conditions of the gastrointestinal tract. Although the exact etiology of IBD remains uncertain, dysfunctional immunoregulation of the gut is believed to be the main culprit. Amongst the immunoregulatory factors, reactive oxygen species are produced in abnormally high levels in IBD. Their destructive effects may contribute to the initiation and/or propagation of the disease. We provided an extensive overview on the evidences from animal and human literature linking oxidative stress to IBD and its activity. Moreover, the effects of antioxidant therapy on IBD patients in randomized, controlled trials were reviewed and the need for further studies elaborated. We also summarized the evidence in support for causality of oxidative stress in IBD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404859     DOI: 10.1007/s10620-006-9622-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  61 in total

Review 1.  Oxidative DNA damage, antioxidants and DNA repair: applications of the comet assay.

Authors:  A R Collins; E Horváthová
Journal:  Biochem Soc Trans       Date:  2001-05       Impact factor: 5.407

2.  Oxidative stress, vitamin A and vitamin E behaviour in patients submitted to conservative surgery for complicated Crohn's disease.

Authors:  G M Sampietro; M Cristaldi; G Cervato; G Maconi; P Danelli; R Cervellione; M Rovati; G Bianchi Porro; B Cestaro; A M Taschieri
Journal:  Dig Liver Dis       Date:  2002-10       Impact factor: 4.088

Review 3.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

Authors:  Barry Halliwell; Matthew Whiteman
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

4.  Breath alkanes determination in ulcerative colitis and Crohn's disease.

Authors:  M A Pelli; G Trovarelli; E Capodicasa; G E De Medio; G Bassotti
Journal:  Dis Colon Rectum       Date:  1999-01       Impact factor: 4.585

5.  Biochemical and histopathological evidences for beneficial effects of satureja khuzestanica jamzad essential oil on the mouse model of inflammatory bowel diseases.

Authors:  Ghazal Ghazanfari; Bagher Minaie; Narges Yasa; Leila Ashtaral Nakhai; Azadeh Mohammadirad; Shekoufeh Nikfar; Gholamreza Dehghan; Vahid Shetab Boushehri; Hamidreza Jamshidi; Reza Khorasani; Alinazar Salehnia; Mohammad Abdollahi
Journal:  Toxicol Mech Methods       Date:  2006       Impact factor: 2.987

6.  Superoxide production by polymorphonuclear leukocytes. A cytochemical approach.

Authors:  R T Briggs; J M Robinson; M L Karnovsky; M J Karnovsky
Journal:  Histochemistry       Date:  1986

7.  Circulating antioxidant concentrations in children with inflammatory bowel disease.

Authors:  E J Hoffenberg; J Deutsch; S Smith; R J Sokol
Journal:  Am J Clin Nutr       Date:  1997-05       Impact factor: 7.045

8.  Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease.

Authors:  Ioannis E Koutroubakis; Niki Malliaraki; Philippos D Dimoulios; Konstantinos Karmiris; Elias Castanas; Elias A Kouroumalis
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

9.  Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease.

Authors:  Laurens Kruidenier; Ineke Kuiper; Wim Van Duijn; Marij A C Mieremet-Ooms; Ruud A van Hogezand; Cornelis B H W Lamers; Hein W Verspaget
Journal:  J Pathol       Date:  2003-09       Impact factor: 7.996

10.  Hydrogen peroxide enteritis: the "snow white" sign.

Authors:  J J Bilotta; J D Waye
Journal:  Gastrointest Endosc       Date:  1989 Sep-Oct       Impact factor: 9.427

View more
  161 in total

1.  p53 antibodies, metallothioneins, and oxidative stress markers in chronic ulcerative colitis with dysplasia.

Authors:  Hala E Hamouda; Soha S Zakaria; Saber A Ismail; Mahmoud A Khedr; Wael W Mayah
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

Review 2.  A review of the efficacy of traditional Iranian medicine for inflammatory bowel disease.

Authors:  Roja Rahimi; Mohammad Reza Shams-Ardekani; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

Review 3.  Ion channel remodeling in gastrointestinal inflammation.

Authors:  H I Akbarali; E G Hawkins; G R Ross; M Kang
Journal:  Neurogastroenterol Motil       Date:  2010-07-05       Impact factor: 3.598

Review 4.  ROS in gastrointestinal inflammation: Rescue Or Sabotage?

Authors:  G Aviello; U G Knaus
Journal:  Br J Pharmacol       Date:  2016-03-03       Impact factor: 8.739

5.  Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis.

Authors:  Mahsa Moeinian; Seyedeh Farnaz Ghasemi-Niri; Shilan Mozaffari; Amir Hossein Abdolghaffari; Maryam Baeeri; Mona Navaea-Nigjeh; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

6.  A meta-analysis of antibiotic therapy for active ulcerative colitis.

Authors:  Roja Rahimi; Shekoufeh Nikfar; Ali Rezaie; Mohammad Abdollahi
Journal:  Dig Dis Sci       Date:  2007-04-06       Impact factor: 3.199

7.  Maternal obesity induces gut inflammation and impairs gut epithelial barrier function in nonobese diabetic mice.

Authors:  Yansong Xue; Hui Wang; Min Du; Mei-Jun Zhu
Journal:  J Nutr Biochem       Date:  2014-04-01       Impact factor: 6.048

Review 8.  Antioxidant therapy in the management of acute, chronic and post-ERCP pancreatitis: a systematic review.

Authors:  Seyed Sajad Mohseni Salehi Monfared; Hamed Vahidi; Amir Hossein Abdolghaffari; Shekoufeh Nikfar; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

9.  Sophora flavescens Containing-QYJD Formula Activates Nrf2 Anti-Oxidant Response, Blocks Cellular Transformation and Protects Against DSS-Induced Colitis in Mouse Model.

Authors:  Ruoming Fang; Renyi Wu; Qian Zuo; Ran Yin; Chengyue Zhang; Chao Wang; Yue Guo; Anne Yuqing Yang; Wenji Li; Lizhu Lin; Ah-Ng Kong
Journal:  Am J Chin Med       Date:  2018-10-04       Impact factor: 4.667

10.  Bolus injection of newly synthesized vitamin E derivative ETS-GS for the treatment of acute severe ulcerative colitis in a mouse model. New vitamin E derivative for acute severe UC.

Authors:  Takahiro Hiratsuka; Masafumi Inomata; Satoshi Hagiwara; Yohei Kono; Norio Shiraishi; Takayuki Noguchi; Seigo Kitano
Journal:  Int J Colorectal Dis       Date:  2012-07-31       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.